Share Print

Hematopoietic Development and Malignancy

Program Leaders: Daniel Link, MD, PhD, and Peter Westervelt, MD, PhD 

The Hematopoietic Development and Malignancy Program (HDMP) includes 29 Washington University faculty members from four departments. The long-term goals of the HDMP are to elucidate basic mechanisms regulating normal and malignant hematopoiesis and use this information to develop strategies for the prevention, diagnosis, prognostic stratification and treatment of hematopoietic malignancies. We have identified areas of institutional strength and developed the following specific translational goals:

  • To leverage local expertise in cancer genomics to identify key genetic and epigenetic alterations in hematopoietic malignancies and develop their translational potential
  • To Develop fundamental discoveries in immunology into novel immunotherapies for hematopoietic malignancies
  • To translate fundamental discoveries in stem cell biology into novel strategies to treat hematopoietic malignancies and/or improve stem cell transplantation
  • To expand translational research in multiple myeloma and lymphoma

Groups in leukemia, lymphoma & myeloma, myelodysplastic syndrome and transplantation biology have been established to develop, review, prioritize and conduct translational research. The HDMP fosters collaborative translational research and provides training of junior investigators through research seminars, journal clubs, work-in-progress meetings and the annual HDMP retreat.


Click on the name to see detailed information about the selected professional.

Camille Abboud, MD Internal Medicine
Abdel Kareem Azab, PhD Radiation Oncology
Nancy Bartlett, MD Internal Medicine
Luis Batista, PhD Internal Medicine
Morey Blinder, MD Internal Medicine
Amanda Cashen, MD Internal Medicine
Grant Challen, PhD Internal Medicine
Kyunghee Choi, PhD Pathology and Immunology
Megan Cooper, MD, PhD Pediatrics
Mary Dinauer, MD, PhD Pediatrics
John DiPersio, MD, PhD Internal Medicine
Todd Druley, MD, PhD Pediatrics
Internal Medicine
Todd Fehniger, MD, PhD Internal Medicine
Anjum Hassan, MD Pathology and Immunology
Friederike Kreisel, MD Pathology and Immunology
Shashikant Kulkarni, PhD Pathology and Immunology
Timothy Ley, MD Internal Medicine
Daniel Link, MD Internal Medicine
Lisa Madden, MD Pediatrics
Jeffrey Magee, MD, PhD Pediatrics
Tu-Dung Nguyen, MD, PhD Pathology and Immunology
Stephen Oh, MD, PhD Internal Medicine
Jacqueline Payton, MD, PhD Pathology and Immunology
Iskra Pusic, MD Internal Medicine
Lee Ratner, MD, PhD Internal Medicine
Michael Rettig, PhD Internal Medicine
Rizwan Romee, MD Internal Medicine
J. Evan Sadler, MD, PhD Internal Medicine
Mark Sands, PhD Internal Medicine
Andras Schaffer, MD, PhD Pathology and Immunology
Mark Schroeder, MD Internal Medicine
William Shannon, PhD Internal Medicine
Shalini Shenoy, MD Pediatrics
Keith Stockerl-Goldstein, MD Internal Medicine
Christopher Sturgeon, PhD Internal Medicine
Michael Tomasson, MD Internal Medicine
Geoffrey Uy, MD Internal Medicine
Ravi Vij, MD Internal Medicine
Matthew Walter, MD Internal Medicine
Lukas Wartman, MD Internal Medicine
John Welch, MD, PhD Internal Medicine
Peter Westervelt, MD, PhD Internal Medicine
David Wilson, MD, PhD Pediatrics
Richard Wilson, PhD Genetics
Nabeel Yaseen, MD, PhD Pathology and Immunology